Literature DB >> 24352242

A molecular marker of artemisinin-resistant Plasmodium falciparum malaria.

Frédéric Ariey1, Benoit Witkowski2, Chanaki Amaratunga3, Johann Beghain1, Anne-Claire Langlois4, Nimol Khim2, Saorin Kim2, Valentine Duru2, Christiane Bouchier5, Laurence Ma5, Pharath Lim6, Rithea Leang7, Socheat Duong7, Sokunthea Sreng7, Seila Suon7, Char Meng Chuor7, Denis Mey Bout8, Sandie Ménard9, William O Rogers10, Blaise Genton11, Thierry Fandeur12, Olivo Miotto13, Pascal Ringwald14, Jacques Le Bras15, Antoine Berry9, Jean-Christophe Barale1, Rick M Fairhurst16, Françoise Benoit-Vical17, Odile Mercereau-Puijalon18, Didier Ménard19.   

Abstract

Plasmodium falciparum resistance to artemisinin derivatives in southeast Asia threatens malaria control and elimination activities worldwide. To monitor the spread of artemisinin resistance, a molecular marker is urgently needed. Here, using whole-genome sequencing of an artemisinin-resistant parasite line from Africa and clinical parasite isolates from Cambodia, we associate mutations in the PF3D7_1343700 kelch propeller domain ('K13-propeller') with artemisinin resistance in vitro and in vivo. Mutant K13-propeller alleles cluster in Cambodian provinces where resistance is prevalent, and the increasing frequency of a dominant mutant K13-propeller allele correlates with the recent spread of resistance in western Cambodia. Strong correlations between the presence of a mutant allele, in vitro parasite survival rates and in vivo parasite clearance rates indicate that K13-propeller mutations are important determinants of artemisinin resistance. K13-propeller polymorphism constitutes a useful molecular marker for large-scale surveillance efforts to contain artemisinin resistance in the Greater Mekong Subregion and prevent its global spread.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24352242      PMCID: PMC5007947          DOI: 10.1038/nature12876

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  61 in total

1.  Evidence of artemisinin-resistant malaria in western Cambodia.

Authors:  Harald Noedl; Youry Se; Kurt Schaecher; Bryan L Smith; Duong Socheat; Mark M Fukuda
Journal:  N Engl J Med       Date:  2008-12-08       Impact factor: 91.245

2.  Gene disruptions demonstrate independent roles for the four falcipain cysteine proteases of Plasmodium falciparum.

Authors:  Puran S Sijwali; Jamie Koo; Naresh Singh; Philip J Rosenthal
Journal:  Mol Biochem Parasitol       Date:  2006-07-20       Impact factor: 1.759

3.  Deamplification of pfmdr1-containing amplicon on chromosome 5 in Plasmodium falciparum is associated with reduced resistance to artelinic acid in vitro.

Authors:  Nanhua Chen; Marina Chavchich; Jennifer M Peters; Dennis E Kyle; Michelle L Gatton; Qin Cheng
Journal:  Antimicrob Agents Chemother       Date:  2010-04-26       Impact factor: 5.191

4.  A major genome region underlying artemisinin resistance in malaria.

Authors:  Ian H Cheeseman; Becky A Miller; Shalini Nair; Standwell Nkhoma; Asako Tan; John C Tan; Salma Al Saai; Aung Pyae Phyo; Carit Ler Moo; Khin Maung Lwin; Rose McGready; Elizabeth Ashley; Mallika Imwong; Kasia Stepniewska; Poravuth Yi; Arjen M Dondorp; Mayfong Mayxay; Paul N Newton; Nicholas J White; François Nosten; Michael T Ferdig; Timothy J C Anderson
Journal:  Science       Date:  2012-04-06       Impact factor: 47.728

5.  Increased tolerance to artemisinin in Plasmodium falciparum is mediated by a quiescence mechanism.

Authors:  Benoit Witkowski; Joel Lelièvre; María José López Barragán; Victor Laurent; Xin-zhuan Su; Antoine Berry; Françoise Benoit-Vical
Journal:  Antimicrob Agents Chemother       Date:  2010-02-16       Impact factor: 5.191

6.  Identification of a mutant PfCRT-mediated chloroquine tolerance phenotype in Plasmodium falciparum.

Authors:  Stephanie G Valderramos; Juan-Carlos Valderramos; Lise Musset; Lisa A Purcell; Odile Mercereau-Puijalon; Eric Legrand; David A Fidock
Journal:  PLoS Pathog       Date:  2010-05-13       Impact factor: 6.823

7.  The Plasmodium falciparum protein Pfg27 is dispensable for gametocyte and gamete production, but contributes to cell integrity during gametocytogenesis.

Authors:  Anna Olivieri; Grazia Camarda; Lucia Bertuccini; Marga van de Vegte-Bolmer; Adrian J F Luty; Robert Sauerwein; Pietro Alano
Journal:  Mol Microbiol       Date:  2009-06-30       Impact factor: 3.501

8.  Artemisinin resistance in Plasmodium falciparum malaria.

Authors:  Arjen M Dondorp; François Nosten; Poravuth Yi; Debashish Das; Aung Phae Phyo; Joel Tarning; Khin Maung Lwin; Frederic Ariey; Warunee Hanpithakpong; Sue J Lee; Pascal Ringwald; Kamolrat Silamut; Mallika Imwong; Kesinee Chotivanich; Pharath Lim; Trent Herdman; Sen Sam An; Shunmay Yeung; Pratap Singhasivanon; Nicholas P J Day; Niklas Lindegardh; Duong Socheat; Nicholas J White
Journal:  N Engl J Med       Date:  2009-07-30       Impact factor: 91.245

9.  The Plasmodium falciparum translationally controlled tumor protein homolog and its reaction with the antimalarial drug artemisinin.

Authors:  J Bhisutthibhan; X Q Pan; P A Hossler; D J Walker; C A Yowell; J Carlton; J B Dame; S R Meshnick
Journal:  J Biol Chem       Date:  1998-06-26       Impact factor: 5.157

10.  Novel polymorphisms in Plasmodium falciparum ABC transporter genes are associated with major ACT antimalarial drug resistance.

Authors:  Maria Isabel Veiga; Pedro Eduardo Ferreira; Louise Jörnhagen; Maja Malmberg; Aminatou Kone; Berit Aydin Schmidt; Max Petzold; Anders Björkman; Francois Nosten; Jose Pedro Gil
Journal:  PLoS One       Date:  2011-05-25       Impact factor: 3.240

View more
  836 in total

Review 1.  Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic.

Authors:  Benjamin Blasco; Didier Leroy; David A Fidock
Journal:  Nat Med       Date:  2017-08-04       Impact factor: 53.440

2.  Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for treatment of uncomplicated malaria in children in Zaire and Uíge Provinces, angola.

Authors:  Mateusz M Plucinski; Eldin Talundzic; Lindsay Morton; Pedro Rafael Dimbu; Aleixo Panzo Macaia; Filomeno Fortes; Ira Goldman; Naomi Lucchi; Gail Stennies; John R MacArthur; Venkatachalam Udhayakumar
Journal:  Antimicrob Agents Chemother       Date:  2014-11-03       Impact factor: 5.191

Review 3.  From within host dynamics to the epidemiology of infectious disease: Scientific overview and challenges.

Authors:  Juan B Gutierrez; Mary R Galinski; Stephen Cantrell; Eberhard O Voit
Journal:  Math Biosci       Date:  2015-10-16       Impact factor: 2.144

Review 4.  Understanding artemisinin-resistant malaria: what a difference a year makes.

Authors:  Rick M Fairhurst
Journal:  Curr Opin Infect Dis       Date:  2015-10       Impact factor: 4.915

5.  Methyl-methoxylpyrrolinone and flavinium nucleus binding signatures on falcipain-2 active site.

Authors:  Olaposi I Omotuyi
Journal:  J Mol Model       Date:  2014-08-06       Impact factor: 1.810

6.  A Single Mutation in K13 Predominates in Southern China and Is Associated With Delayed Clearance of Plasmodium falciparum Following Artemisinin Treatment.

Authors:  Fang Huang; Shannon Takala-Harrison; Christopher G Jacob; Hui Liu; Xiaodong Sun; Henglin Yang; Myaing M Nyunt; Matthew Adams; Shuisen Zhou; Zhigui Xia; Pascal Ringwald; Maria Dorina Bustos; Linhua Tang; Christopher V Plowe
Journal:  J Infect Dis       Date:  2015-04-24       Impact factor: 5.226

7.  Analogs of natural aminoacyl-tRNA synthetase inhibitors clear malaria in vivo.

Authors:  Eva Maria Novoa; Noelia Camacho; Anna Tor; Barrie Wilkinson; Steven Moss; Patricia Marín-García; Isabel G Azcárate; José M Bautista; Adam C Mirando; Christopher S Francklyn; Sònia Varon; Miriam Royo; Alfred Cortés; Lluís Ribas de Pouplana
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-08       Impact factor: 11.205

8.  Identification and deconvolution of cross-resistance signals from antimalarial compounds using multidrug-resistant Plasmodium falciparum strains.

Authors:  Monika Chugh; Christian Scheurer; Sibylle Sax; Elizabeth Bilsland; Donelly A van Schalkwyk; Kathryn J Wicht; Natalie Hofmann; Anil Sharma; Sridevi Bashyam; Shivendra Singh; Stephen G Oliver; Timothy J Egan; Pawan Malhotra; Colin J Sutherland; Hans-Peter Beck; Sergio Wittlin; Thomas Spangenberg; Xavier C Ding
Journal:  Antimicrob Agents Chemother       Date:  2014-12-08       Impact factor: 5.191

9.  Polymorphisms in the K13-propeller gene in artemisinin-susceptible Plasmodium falciparum parasites from Bougoula-Hameau and Bandiagara, Mali.

Authors:  Amed Ouattara; Aminatou Kone; Matthew Adams; Bakary Fofana; Amelia Walling Maiga; Shay Hampton; Drissa Coulibaly; Mahamadou A Thera; Nouhoum Diallo; Antoine Dara; Issaka Sagara; Jose Pedro Gil; Anders Bjorkman; Shannon Takala-Harrison; Ogobara K Doumbo; Christopher V Plowe; Abdoulaye A Djimde
Journal:  Am J Trop Med Hyg       Date:  2015-04-27       Impact factor: 2.345

10.  Artemisinin Resistance-Associated K13 Polymorphisms of Plasmodium falciparum in Southern Rwanda, 2010-2015.

Authors:  Costanza Tacoli; Prabhanjan P Gai; Claude Bayingana; Kevin Sifft; Dominik Geus; Jules Ndoli; Augustin Sendegeya; Jean Bosco Gahutu; Frank P Mockenhaupt
Journal:  Am J Trop Med Hyg       Date:  2016-08-29       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.